Lung donors selection criteria: A review

Journal of Cardiovascular Surgery

Volumn 47, Issue 3, 2006, Pages 361-366

  Filosso, Pierluigi L ^a   Turello, D ^a   Cavallo, A ^a   Ruffini, E ^a   Mancuso, M ^a   Oliaro, A ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Allograft; Lung transplantation; Organ donor management

Indexed keywords

ANTIBIOTIC AGENT; OXYGEN;

AGE DISTRIBUTION; ARTERIAL GAS; ARTERIAL OXYGEN SATURATION; ARTIFICIAL VENTILATION; BLOOD GROUP ABO INCOMPATIBILITY; BRAIN DEATH; CAUSE OF DEATH; DONOR SELECTION; EVIDENCE BASED MEDICINE; EXPERIENCE; GRAFT FAILURE; HOSPITAL ADMISSION; HUMAN; INTUBATION; LUNG FUNCTION; LUNG INFECTION; LUNG INSUFFICIENCY; LUNG LAVAGE; LUNG TRANSPLANTATION; PNEUMONIA; PUBLIC OPINION; QUALITY CONTROL; REPERFUSION INJURY; REVIEW; SEX DIFFERENCE; THORAX RADIOGRAPHY; TIME; TREATMENT OUTCOME;

BRAIN DEATH; CADAVER; DONOR SELECTION; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; PULMONARY CIRCULATION;

EID: 33745930200     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Bratton SL, Davis RL. Acute lung injury in isolated traumatic brain injury. Neurosurgery 1997;40:707-12.
2. Pennefather SH, Bullock RE, Dark JH. The effect of fluid therapy on alveolar arterial oxygen gradient in brain-dead organ donors. Transplantation 1993;56:418-22.
3. Chen EP, Bitter HB, Kendall SW, Van Trigt P. Hormonal and haemodinamic changes in a validated model of brain death. Crit Care Med 1996;24:1352-9.
4. Wicomb WN, Cooper DK, Lanza RP, Novitzky D, Isaacs S. The effects of brain death and 24 hours' storage by hypotermic perfusion on donor heart function in the pig. J Thorac Cardiovasc Surg 1986;91:896-909.
5. Ware LB, Fang X, Wang Y, Sakuma T, Hall TS, Matthay MA. Selected contribution: mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung. J Appl Physiol 2002;93:1869-74.
6. Pennefather SH, Bullock RE, Mantle D, Dark JH. Use of low dose arginine vasopressine to support brain-dead organ donors. Transplantation 1995;59:58-62.
7. Chen JM, Cullinane S, Spanier TB, Artrip JH, Ranjit J, Edwards NM et al. Vasopressin deficiency and pressor hypersensibility in hemodynamically unstable organ donors. Circulation 1999;100 Suppl 19:II244-6.
8. Iway A, Sakano T, Uenishi M, Sugimoto H, Yoshioka T, Sugimoto T. Effects of vasopressin and cathecolamines on the maintenance of circulatory stability in brain-dead patients. Transplantation 1989;48:613-7.
9. Wheeldon DR, Potter CD, Oduro A, Wallwork J, Large SR. Transforming the "unacceptable" donor: outcome from the adoption of a standardized donor management thecnique. J Heart Lung Transplant 1995; 14:734-42.
10. Cooper DK, Novitzky D, Wicomb WN. The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. Ann R Coll Surg Engl 1989;71:261-6.
11. Sundaresan S, Trachiotis G, Aoe M, Patterson AG, Cooper J. Donor lung procurement: assessment and operative technique. Ann Thorac Surg 1993;56:1409-13.
12. Puskas JD, Winton TL, Miller JD, Scavuzzo M, Patterson GA. Unilateral donor lung dysfunction does not preclude successful contralateral single lung transplantation. J Thorac Cardiovasc Surg 1992;103:1015-8.
13. Sundaresan S, Semenkovich J, Ochoa L, Richardson G, Trulock EP, Cooper JD et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg 1995;109:1075-9.
14. Gabbay E, Williams TJ, Griffiths AP, Macfarlane LM, Kotsimbos TC, Esmore DS et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 1999;160:265-71.
15. Bhorade SM, Vigneswaran W, McCabe MA, Garrity ER. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung tranplantation. J Heart Lung Transplant 2000;19:1199-204.
16. Straznicka M, Follette DM, Eisner MD, Roberts PF, Menza RL, Babcock WD. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 2002;124:250-8.
17. United Network for Organ Sharing. Guidelines for multiorgan donor management and procurement. UNOS update 1993.p. 14-5.
18. Novick RJ, Bennett LE, Meyer DM, Hosenpund JD. Influence of graft ischemic time and donor age on survival after lung transplantation. J Heart Lung Transplant 1999;18:425-31.
19. Hosenpund JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The registry of the International Society for Heart and Lung Transplantation: eighteen official report-2001. J Heart Lung Transplant 2001;20:805-15.
20. Fisher S, Gohrbandt B, Struckmeier P, Niedermeyer J, Simon A, Hagl C et al. Lung transplantation with lungs from donors fifty years of age and older. J Thorac Cardiovasc Surg 2005;129:919-25.
21. Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998;17:423-9.
22. Luckraz H, White P, Sharples ID, Hopkins P. Wallwork J. Short- and long-term outcomes of using pulmonary allograft donors with low P02. J Heart Lung Transplant 2005;24:470-3.
23. Pierre AF, Sekine Y, Hutcheon M, Waddell TK, Keshavjiee S. Marginal lung donors: a reassessment. J Thorac Cardiovasc Surg 2002;123:421-8.
24. Sekine Y, Waddell TK, Matte-Martyn A, Pierre AF, de Perrot M, Fischer S et al. Risk quantification of early outcome after lung transplantation: donor, recipient, operative, and post-transplant parameters. J Heart Lung Transplant 2004;23:96-104.
25. Zenati M, Dowling RD, Armitage JM, Komos RL, Dummer JS, Hardesty RL et al. Organ procurement for pulmonary transplantation. Ann Thorac Surg 1989;48:882-6.
26. Dowling RD, Williams P, Zenati M, Griffith BP, Hardestry RL. Infections and pathologic factors in the donor lung. J Thorac Cardiovasc Surg 1995;109:1263-4.
27. Weill D, Dey GC, Hicks RA, Yong KR, Zorn GL, Kirklin JK et al. A positive donor gram stain does not predict outcome following lung transplantation. J Heart Lung Transplant 2002;21:555-8.
28. Harjula A, Baldwin JC, Starnes VA, Harjula A, Baldwin JC, Starnes VA et al. Proper donor selection for heart-lung transplantation. The Stanford experience. J Thorac Cardiovasc Surg 1987;94:874-80.
29. Griffith BP, Zenati M. The pulmonary donor. Clin Chest Med 1990;11:217-26.
30. Stewart S, Ciulli F, Wells FC, Wallwork J. Pathology of unused donor lungs. Transplant Proc 1993;25:1167-8.
31. Avlonitis VS, Krause A, Luzzi L, Powell H, Phillips JA, Corris P et al. Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation. Eur J Cardiothorac Surg 2003;24:601-7.
32. Zenati M, Dowling RD, Dummer JS, Paradis IL, Arena VC, Armitage JM et al. Influence of the donor lung on development of early infections in lung transplant recipients. J Heart Lung Transplant 1990;9:502-9.
33. Dowling RD, Zenati M, Yousem SA, Pasculle AW, Kormos RL, Armitage JA et al. Donor-transmitted pneumonia in experimental lung allografts. Successful prevention with donor antibiotic therapy. J Thorac Cardiovasc Surg 1992;103:767-72.
34. Low DE, Kaiser LE, Haydock DA, Trulock E, Cooper JD. The donor lung: infectious and pathological factors affecting outcome in lung transplantation. J Thorac Cardiovasc Surg 1993;106:614-21.
35. Gammie JS, Stukus DR, Pham SM, Hattler BG, McGrath MF, McCurry KR et al. Effect of ischemic time on survival in clinical lung transplantation. Ann Thorac Surg 1999;68:2015-20.
36. Fiser SM, Kron IL, Long SM, Kaza AK, Kern JA, Cassada DC et al. Influence of graft ischemic time on outcome following lung transplantation. J Heart Lung Transplant 2001;20:1291-6.
37. Ksettry VR, Kroshus TJ, Burdine J, Savik K, Bolman RM 3rd. Does donor organ ischemia over four hours affect long-term survival after lung transplantation? J Heart Lung Transplant 1996;15:169-74.
38. Ciccone AM, Stewart KC, Meyers BF, Guthrie TJ, Battafarano RJ, Trulock EP et al. Does donor cause of death affect the outcome of lung transplantation? J Thorac Cardiovasc Surg 2002;123:429-36.
39. Torres A, El-Ebiary A, Rano A. Respiratory infectious complications in the intensive care unit. Clin Chest Med 1999;20:287-301.